Searched for
GENERIC ANTI EPILEPTIC MEDICATION
Karnataka: Chief Minister Shivakumar warns gutkha industry of ban if substances are foundKarnataka Chief Minister D K Shivakumar has warned the pan masala and gutkha industry of an outright ban if any intoxicating substances are...- Karnataka CM Shivakumar warns of ban on pan masala, gutka containing narcotic substancesKarnataka Chief Minister D K Shivakumar has vowed to ban pan masala and gutka if found laced with intoxicating substances, warning manufact...
- Health ministry proposes faster approvals for medical device manufacturing licencesThe Union health ministry is proposing to significantly cut down the time taken to issue manufacturing licenses for medical devices. Aimed ...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- Assam Police arrest two ULFA (I) cadres, foil alleged attack plotAssam Police, acting on specific intelligence inputs and with support from central security agencies, foiled an alleged terror plot by arre...
- AI platform developed to support doctors, frontline workers with verified health intelligenceA Chennai-based epidemiologist has launched HIVE, an AI-powered platform designed to deliver verified, evidence-based healthcare intelligen...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Psychology explains why some people are terrified before flying, and it may have less to do with the plane itselfPsychology suggests intense pre-flight anxiety, or aviophobia, is strongly linked to past stressful experiences and burnout. A 2024 study f...
- Centre eyes medical tourism boost with funding support for hospitalsIndia is gearing up to become a global medical tourism powerhouse with a new government scheme. Funding will boost hospitals, colleges, and...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Govt eyes fast-tracking local production of high-end medical devicesIndia is planning to boost local manufacturing of around 10 high-value medical devices, including MRI systems and pacemakers, to curb relia...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Renowned surgeon Dr Dinshaw Pardiwala to lead IOA's anti-doping medical panelIndia's Olympic body is tackling doping with a new medical panel. Dr. Dinshaw Pardiwala will lead the initiative. The panel will work with ...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
Load More
